Moderna (MRNA) has had the highest return since March 27, 2026 by a large-cap US stock, returning 318%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 318.01% |
10X Genomics (TXG) | 306.33% |
Twist Bioscience (TWST) | 272.29% |
Netskope, Inc Class A Common Stock (NTSK) | 215.54% |
Atlassian (TEAM) | 204.58% |
Okta (OKTA) | 190.96% |
Rubrik (RBRK) | 185.72% |
Crowdstrike (CRWD) | 181.68% |
Advanced Micro Devices (AMD) | 180.73% |
Dell Technologies (DELL) | 173.19% |
Astera Labs (ALAB) | 161.65% |
Micron Technology (MU) | 159.81% |
Palo Alto Networks (PANW) | 157.93% |
Humana (HUM) | 141.24% |
Hewlett Packard Enterprise (HPE) | 138% |
Illumina (ILMN) | 135.82% |
Charles River Laboratories (CRL) | 129.89% |
Glaukos (GKOS) | 127.17% |
Everpure (P) | 123.78% |
Natera (NTRA) | 122.8% |
Jfrog (FROG) | 122.34% |
Sandisk (SNDK) | 121.77% |
Datadog (DDOG) | 121.53% |
Marvell Technology (MRVL) | 121.25% |
Avantor (AVTR) | 119.76% |
Large-cap stocks are treated as having a market cap of $10B+.